Musculoskeletal Disorders
Guidelines
New JIA guidelines emphasize earlier DMARD use
Advances in understanding and treating systemic JIA have led practitioners away from steroids and toward using conventional synthetic and biologic...
Feature
Eighteen-year study shows inconsistencies in treating, classifying JIA
A long-term study of children with juvenile idiopathic arthritis highlights an inconsistent classification system and hints about how they manage...
Latest News
CDC, AAP issues new guidelines to better define developmental milestones
“The goals of the group were to identify evidence-informed milestones to include in CDC checklists, clarify when most children can be expected to...
From the Journals
Tofacitinib yields rapid and sustained improvement in juvenile idiopathic arthritis
The phase 3 trial looked at flare rate out to 44 weeks after patients first met response criteria following 18 weeks of open-label treatment with...
Commentary
When the evidence suggests that placebo is best
What they discovered is that no type of injection therapy has been proven to be better than a saline injection.
Conference Coverage
Drug combo at outset of polyarticular JIA benefits patients most
Despite the wariness that some families and even providers have about starting JIA therapy with both a biologic and conventional DMARD, new data...
Latest News
High-dose constraint-induced movement therapy effective in cerebral palsy
At six months, children who received the higher dose of CIMT with a cast or a splint had significantly greater improvements in a wide range of...
Latest News
European agency recommends two new adalimumab biosimilars
The Committee for Medicinal Products for Human Use gave a positive opinion for the approval of Hukyndra and Libmyris, each of which will have 15...
News from the FDA/CDC
Three JAK inhibitors get boxed warnings, modified indications
The FDA is limiting all approved uses of tofacitinib, baricitinib, and upadacitinib to patients who have not responded well to TNF blockers, to...
Conference Coverage
Study informs about risks of discontinuing meds in JIA
If patients with JIA flare after discontinuing therapy, the majority regain disease control when treatment is restarted, according to preliminary...
Guidelines
AAP updates guidance for return to sports and physical activities
For adolescents who are eligible, getting a COVID-19 vaccine may be the most important thing they can do.